Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-19

Clinical Trial Update: A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating the efficacy and safety of a fixed-dose combination of insulin degludec and liraglutide in adults with Type 2 diabetes is planned …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Degludec/Liraglutide

Snippet

Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd | Conditions: Type 2 Diabetes | Phase 3 | Status: NOT_YET_RECRUITING